LORI MAULDIN: Open Payments
NPI 1649221854 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,347 in 101 payments from 17 companies in 2025. Trend: 2023 $760 · 2024 $1,935 · 2025 $2,347
Food & beverage: $2,259Education: $88
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $276 |
| ABBVIE INC. | 16 | $267 |
| GENZYME CORPORATION | 13 | $260 |
| Incyte Corporation | 7 | $260 |
| Regeneron Healthcare Solutions, Inc. | 12 | $210 |
| Arcutis Biotherapeutics, Inc. | 5 | $199 |
| Novartis Pharmaceuticals Corporation | 7 | $134 |
| LEO Pharma Inc. | 5 | $132 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $124 |
| Janssen Biotech, Inc. | 5 | $92 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, OPZELURA, Zoryve, COSENTYX, ADBRY, TREMFYA.
Industry payments across SC — which companies pay providers there.
